Related Experiment Video
Updated: Jun 3, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Left ventricular non-compaction in children and adolescents: clinical features, treatment and follow-up
Yakup Ergul1, Kemal Nisli, Atalay Demirel
1Department of Pediatric Cardiology, Istanbul University, Istanbul Faculty of Medicine, Turkey. yakupergul77@hotmail.com
Insights
Left ventricular non-compaction (LVNC) is a rare heart muscle disease diagnosed in children. Early recognition of symptoms like heart failure and cardiomegaly is crucial for timely diagnosis and management of pediatric LVNC.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Cardiomyopathy Research
Background:
- Left ventricular non-compaction (LVNC) is a distinct cardiomyopathy arising from disrupted endomyocardial morphogenesis.
- This study focuses on the clinical presentation, diagnostic markers, therapeutic interventions, and outcomes of pediatric patients diagnosed with LVNC.
Purpose of the Study:
- To present comprehensive clinical findings, diagnostic features, treatment strategies, and follow-up data for pediatric patients with LVNC.
- To highlight the variability in clinical course and age of diagnosis for LVNC in children.
- To emphasize the importance of recognizing specific symptoms for earlier LVNC diagnosis.
Main Methods:
- Retrospective analysis of pediatric patients diagnosed with LVNC between January 2006 and March 2010.
- Diagnosis confirmed via characteristic findings on magnetic resonance imaging (MRI) and echocardiography.
- Additional diagnostic tools included Holter electrocardiography and metabolic screening.
Main Results:
- The study included 24 pediatric patients (18 male, 6 female) with LVNC, diagnosed between 8 days and 15 years of age.
- Common presenting symptoms included heart failure (33%), rhythm abnormalities (20%), and cardiomegaly (20%). Electrocardiographic abnormalities were prevalent (87.5%).
- Follow-up revealed the need for a pacemaker in one patient, and three patient deaths. Metabolic disorders were identified in two patients.
Conclusions:
- LVNC can be diagnosed across all pediatric age groups, from neonates to adolescents, exhibiting a variable clinical trajectory.
- Prompt evaluation of children presenting with cardiomegaly and heart failure is essential to expedite LVNC diagnosis.
- Increased awareness and diagnostic vigilance can improve outcomes for pediatric patients with LVNC.
Background:
Left ventricular non-compaction (LVNC) is a specific cardiomyopathy that occurs following a disruption of endomyocardial morphogenesis. This study presents clinical findings, diagnostic features, treatment and follow-up of pediatric patients diagnosed with LVNC.
Methods:
Patients with LVNC who were followed from January 2006 to March 2010 were included in this study. Diagnosis was made with the use of characteristic findings of magnetic resonance imaging and echocardiography. Holter electrocardiography and metabolic screening tests were also performed in all patients.
Results:
A total of 24 patients were studied (18 male, six female). Patient age at diagnosis was 50 ± 60 months (eight days to 15 years). Average follow-up period was 22 ± 12 months (four months to four years). Findings at diagnosis were as follows: eight (33%) patients had heart failure, five (20%) had rhythm abnormalities, five (20%) had cardiomegaly, two had murmurs, two had cyanosis, and two presented with fatigue. Ten (41%) patients had been followed previously with other diagnoses. In 21 (87.5%) patients, electrocardiographic abnormalities were noted, especially left ventricular hypertrophy and ST-T changes. Patients had an average ejection fraction of 46% (18-73%) and three of them had additional congenital heart disease (patent ductus arteriosus, aortopulmonary window and complex cyanotic heart disease). Scanning for metabolic diseases revealed fatty acid oxidation disorder in one patient, and mitochondrial disease in another. During follow-up, a permanent pacemaker was implanted in a patient with severe bradycardia and ventricular dysfunction, and three patients died.
Conclusion:
LVNC can be diagnosed at any age from newborn to adolescent and has a variable clinical course. Closer study of patients with cardiomegaly and heart failure can reduce delays in diagnosis of LVNC.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification